Genomic Risk in Retroperitoneal Sarcoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Genomic Risk in Retroperitoneal Sarcoma — Stella

Home/Retroperitoneal Liposarcoma/

View on ClinicalTrials.gov

Recruiting

Back to Retroperitoneal Liposarcoma trials

Trial locations(1 site)

United States

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Key details

Sponsor

Fox Chase Cancer Center

Enrollment target

~50 participants

Started

March 2022

Primary completion

June 2027

Age range

18 Years and older

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.